SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001437749-15-017766
Filing Date
2015-09-28
Accepted
2015-09-28 15:54:21
Documents
1
Period of Report
2015-09-25

Document Format Files

Seq Description Document Type Size
1 FORM 4 rdgdoc.html 4  
1 FORM 4 rdgdoc.xml 4 4118
  Complete submission text file 0001437749-15-017766.txt   5755
Mailing Address 2500 NORTHWINDS PARKWAY, SUITE 100 ALPHARETTA 2Q 30009
Business Address 2500 NORTHWINDS PARKWAY, SUITE 100 ALPHARETTA 2Q 30009 301-770-3099
Biota Pharmaceuticals, Inc. (Issuer) CIK: 0000072444 (see all company filings)

IRS No.: 591212264 | State of Incorp.: DE | Fiscal Year End: 0630
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences

Mailing Address 12270 WILKINS AVENUE ROCKVILLE MD 20852
Business Address
PATTI JOSEPH M (Reporting) CIK: 0001283215 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35285 | Film No.: 151127419